Kenvue (KVUE) Stock: Kimberly-Clark to Purchase Tylenol Maker for Over $40 Billion

TLDR Kimberly-Clark is acquiring Kenvue for more than $40 billion in a cash and stock deal valued at $48.7 billion total. The merger creates one of the largest consumer health companies in the U.S. with expected combined revenues of $32 billion. Kenvue shareholders will receive $21.01 per share, representing a 46% premium to the last [...]

The post Kenvue (KVUE) Stock: Kimberly-Clark to Purchase Tylenol Maker for Over $40 Billion appeared first on Blockonomi.